Josephine van Dongen

1 General introduction 21 2007;26(12):1099-1104. doi:10.1097/INF.0b013e31814521cb 52. Burnett E, Parashar UD,Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Heal. 2020;8(9):e1195-e1202. doi:10.1016/S2214- 109X(20)30262-X 53. Soares-Weiser K, Bergman H, Henschke N, Pitan F, Cunliffe N.Vaccines for preventing rotavi- rus diarrhoea:Vaccines in use. Cochrane Database Syst Rev. 2019;2019(3). doi:10.1002/14651858. CD008521.pub4 54. Hungerford D, Smith K,Tucker A, et al. Population effectiveness of the pentavalent and mon- ovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2017;17. doi:10.1186/s12879-017-2613-4 55. Javid PJ, Sanchez SE, Jacob S, McNeal MM, Horslen SP, Englund JA.The safety and immuno- genicity of rotavirus vaccination in infants with intestinal failure. J Pediatric Infect Dis Soc . Published online 2014. doi:10.1093/jpids/pit060 56. Fang AYW,Tingay DG. Early observations in the use of oral rotavirus vaccination in infants with functional shor t gut syndrome. J Paediatr Child Health. 2012;48(6):512-516. doi:10.1111/j.1440- 1754.2011.02227.x 57. Public Health England.The Rotavirus Vaccination Programme: Information for Healthcare Professionals.; 2018. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attach- ment_data/file/770826/Rotavirus_vaccination_programme__information_document_Nov_2018.pdf 58. Depar tment AGH. Australian Immunisation Handbook - Rotavirus. 20 September 2019. Pub- lished 2021. Accessed February 5, 2021. https://immunisationhandbook.health.gov.au/vaccine-prevent- able-diseases/rotavirus 59. LeinoT, Ollgren J, Salo H,Tiihonen P, Kilpi T. First year experience of rotavirus immunisation programme in Finland. Vaccine . 2012;31(1):176-182. doi:10.1016/j.vaccine.2012.10.068 60. Hemming M, Räsänen S, Huhti L, Paloniemi M, Salminen M,Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013;172(6):739-746. doi:10.1007/s00431-013-1945-3 61. Marlow R, Muir P,Vipond B, Lyttle M,Trotter C, Finn A. Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom. Eurosurveillance. 2015;20(48):1-7. doi:10.2807/1560- 7917.ES.2015.20.48.30077 62. Raes M, Strens D,Vergison A,Verghote M, Standaer t B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in belgium. Pediatr Infect Dis J . 2011;30(7):120- 125. doi:10.1097/INF.0b013e318214b811 63. John TJ, Samuel R. Herd immunity and herd effect: New insights and definitions. Eur J Epide- miol. 2000;16(7):601-606. doi:10.1023/A:1007626510002 64. Rosettie KL,Vos T, Mokdad AH, et al. Indirect Rotavirus Vaccine Effectiveness for the Prevention of Rotavirus Hospitalization: A Systematic Review and Meta-Analysis. Am J Trop Med Hyg. Published online 2017. doi:10.4269/ajtmh.17-0705 65. Prelog M, Gor th P, Zwazl I, et al. Universal mass vaccination against rotavirus: Indirect effects on rotavirus infections in neonates and unvaccinated young infants not eligible for vaccination. J Infect Dis. Published online 2016. doi:10.1093/infdis/jiw186 66. Valentini D, Ianiro G, Di Bar tolo I, et al. Hospital-acquired Rotavirus and Norovirus Acute Gas- troenteritis in a Pediatric Unit, in 2014-2015; J Med Virol . Published online 2017. doi:10.1002/jmv.24866 67. de Vries LS.Viral Infections and the Neonatal Brain. Semin Pediatr Neurol. 2019;32:100769. doi:10.1016/j.spen.2019.08.005